Promise Shown By Breast Cancer Drug For Treating, Preventing Progestin-Dependent Tumors

News — By on January 30, 2009 at 2:30 pm

Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, such as during hormone replacement therapy. Now, a University of Missouri study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a novel chemotherapeutic treatment for progestin-accelerated human breast cancer.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback